Answers are grounded in this paper and cite their sources.
Supplementary Figure 4. AHCYL1 is selectively critical for KRAS-mutated but not for BRAF-mutated human colorectal cancer cells.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: